|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US9233184||HISAMITSU PHARM CO||Adhesive preparation|| |
(3 years from now)
|US8809615||HISAMITSU PHARM CO||Adhesive preparation|| |
(6 years from now)
Salonpas is owned by Hisamitsu Pharm Co.
Salonpas contains Menthol; Methyl Salicylate.
Salonpas has a total of 2 drug patents out of which 0 drug patents have expired.
Salonpas was authorised for market use on 20 February, 2008.
Salonpas is available in patch;topical dosage forms.
The generics of Salonpas are possible to be released after 03 January, 2030.
Market Authorisation Date: 20 February, 2008
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic